Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | IMA401 |
Synonyms | |
Therapy Description |
Limited information is currently available on IMA401, a putative T-cell engager (TCER) that targets an MAGEA4 and MAGEA8 derived peptide (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IMA401 | IMA-401|IMA 401 | Limited information is currently available on IMA401, a putative T-cell engager (TCER) that targets an MAGEA4 and MAGEA8 derived peptide (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05359445 | Phase I | IMA401 | IMA401 TCER in Recurrent and/or Refractory Solid Tumors | Recruiting | DEU | 0 |